[Prevention of migrainous infarction].
D018674:Adrenergic Antagonists / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002561:Cerebrovascular Disorders / Q000150:complications* / Q000517:prevention & control*; D006801:Humans; D008881:Migraine Disorders / Q000150:complications* / Q000188:drug therapy / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D018674:Adrenergic Antagonists; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002121:Calcium Channel Blockers; D010975:Platelet Aggregation Inhibitors; D017367:Selective Serotonin Reuptake Inhibitors
Prevención del infarto migrañoso.